Delivery Order SPE2DB24D1021-SPE2DB25FEVTH

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,984.40, is a Firm Fixed Price Delivery Order for the supply of TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, a cardiovascular medication. The contract has an ultimate completion date of December 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of TELMISARTAN-HCTZ 80-25 MG TAB 30S, a pharmaceutical product. The contract has a ceiling value of $6,926.18 and a completion date of July 29, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and there is no mention of any subcontractors in the provided...
This is a $1,935.05 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the supply of 4564598993 - TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, with an ultimate completion date of May 15, 2024. This delivery order is placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,829.14, is for the delivery of telmisartan-HCTZ 80-25 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 4, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award from the Defense Logistics Agency (DLA) was issued to the prime contractor Amerisourcebergen Drug Corp for the delivery of TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, a pharmaceutical product. The contract has a total ceiling value of $5,362.48 and is structured as a firm fixed price delivery order with an ultimate completion date of January 8, 2025. The contract is not designated with any set-aside requirements. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,980.67, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in unit dose packages of 30. The contract has an ultimate completion date of April 17, 2025 and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,621.84, is a delivery order for the supply of Telmisartan-HCTZ 80-25 mg tablets. The contract has an ultimate completion date of April 15, 2025 and utilizes a firm fixed price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
This is a $2,514.70 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, a medication used to treat high blood pressure. The contract has a period of performance running through February 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,840.95, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in quantities of 30 per unit. This is a firm-fixed price delivery order contract with a completion date of January 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a large Indefinite Delivery...
This is a $1,871.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4566484748 ! TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, which are used to treat cardiovascular conditions. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEVTH
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,806.50, is for the delivery of TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, which are pharmaceutical tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 9, 2025. The contract was awarded on April 8, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/8/25, 2:29 PM